Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19- associated cytokine storm syndrome: results of the CHIC study'' by Calvo-Aranda et al.
Ramiro S, Mostard R, Landewé RB. Ramiro S, et al. Among authors: mostard r. Ann Rheum Dis. 2023 Feb;82(2):e35. doi: 10.1136/annrheumdis-2020-219534. Epub 2020 Dec 14. Ann Rheum Dis. 2023. PMID: 33318060 No abstract available.
Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study.
Ramiro S, Mostard RLM, Magro-Checa C, van Dongen CMP, Dormans T, Buijs J, Gronenschild M, de Kruif MD, van Haren EHJ, van Kraaij T, Leers MPG, Peeters R, Wong DR, Landewé RBM. Ramiro S, et al. Among authors: mostard rlm. Ann Rheum Dis. 2020 Sep;79(9):1143-1151. doi: 10.1136/annrheumdis-2020-218479. Epub 2020 Jul 20. Ann Rheum Dis. 2020. PMID: 32719045 Free PMC article. Clinical Trial.
Hemocytometric characteristics of COVID-19 patients with and without cytokine storm syndrome on the sysmex XN-10 hematology analyzer.
Martens RJH, van Adrichem AJ, Mattheij NJA, Brouwer CG, van Twist DJL, Broerse JJCR, Magro-Checa C, van Dongen CMP, Mostard RLM, Ramiro S, Landewé RBM, Leers MPG. Martens RJH, et al. Among authors: mostard rlm. Clin Chem Lab Med. 2020 Dec 9;59(4):783-793. doi: 10.1515/cclm-2020-1529. Print 2021 Mar 26. Clin Chem Lab Med. 2020. PMID: 33554540 Free article.
Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'' by De Santis et al.
Ramiro S, Mostard RLM, Landewé RBM. Ramiro S, et al. Ann Rheum Dis. 2023 May;82(5):e112. doi: 10.1136/annrheumdis-2021-220077. Epub 2021 Feb 16. Ann Rheum Dis. 2023. PMID: 33593737 No abstract available.
Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'' by Kaklamanos et al.
Ramiro S, Mostard RLM, Landewé RBM. Ramiro S, et al. Ann Rheum Dis. 2023 Jun;82(6):e135. doi: 10.1136/annrheumdis-2021-220474. Epub 2021 Apr 26. Ann Rheum Dis. 2023. PMID: 33903095 No abstract available.
64 results